Stocktoria
Teladoc Health, Inc. TDOC
NYSE · XNYS · stock · Services-Offices & Clinics of Doctors of Medicine · website · IPO 2015-07-01
Teladoc Health, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.5B | $2.6B | $2.6B | $2.4B | $2.0B |
| R&D expense | $277.9M | $307.3M | $348.5M | $333.6M | $311.9M |
| Operating income | -$263.0M | -$1.0B | -$248.6M | -$13.7B | -$265.6M |
| Interest expense | — | $23.8M | $22.3M | $21.9M | $81.1M |
| Income tax | -$35.2M | $7.6M | $760,000 | -$3.8M | $44.1M |
| Net income | -$200.3M | -$1.0B | -$220.4M | -$13.7B | -$428.8M |
| EPS (diluted) | $-1.14 | $-5.87 | $-1.34 | $-84.60 | $-2.73 |
| Operating cash flow | $294.4M | $293.7M | $350.0M | $189.3M | $194.0M |
| Free cash flow | $285.5M | $282.9M | $338.6M | $172.8M | $185.5M |
| Cash & equivalents | $781.1M | $1.3B | $1.1B | $918.2M | $893.5M |
| Inventory | $38.2M | $38.1M | $29.5M | $56.3M | $73.1M |
| Total assets | $2.9B | $3.5B | $4.4B | $4.3B | $17.7B |
| Total liabilities | $1.5B | $2.0B | $2.1B | — | — |
| Shareholders' equity | $1.4B | $1.5B | $2.3B | $2.3B | $16.0B |
Source: SEC EDGAR filings · CIK 0001477449 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.